Citations 1
S851 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn’s Disease: PROMIS-29 in the SEAVUE Study
Lewis, James D. , Irving, Peter M., Hoops, Timothy, Izanec, James L., Ding, Zhijie , Muser, Erik, Gasink, Christopher , Lewis, James D , Allez, Matthieu , Ma, Tony Xuyen , Panaccione, Remo , Loftus, Edward V. , Danese, Silvio , Sands, Bruce E
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S395-S395
